Holger Thiele
@thiele_holger
Followers
6,572
Following
391
Media
281
Statuses
2,833
cardiologist, trialist, researcher, professor, medical director cardiology Heart Center Leipzig at University of Leipzig, President German Cardiac Society
Leipzig, Deutschland
Joined July 2019
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
#WeAreSeriesEP6
• 393678 Tweets
COME BACK TO ME TEASER
• 208342 Tweets
iPad
• 194908 Tweets
Pablo Marçal
• 146524 Tweets
PondPhuwin WeAre EP6
• 136422 Tweets
Olón
• 114464 Tweets
FURIA ES GRAN HERMANO
• 69847 Tweets
#SRHvLSG
• 57400 Tweets
#XMen97
• 51472 Tweets
Bruno Mars
• 50136 Tweets
Natalie Elphicke
• 49789 Tweets
Suki
• 47873 Tweets
Mother's Day
• 45809 Tweets
ANTT
• 43538 Tweets
Chromatica Ball
• 41804 Tweets
THE A'TIN OF SB19
• 40962 Tweets
SHEE SLAYS AT 20
• 31165 Tweets
Gazzede SoykırımaDurDe
• 29083 Tweets
Steve Albini
• 28894 Tweets
Santiago Bernabéu
• 26440 Tweets
#乃木坂46ANN
• 25105 Tweets
Piers Morgan
• 22831 Tweets
1st Dream of FAYMAY
• 22330 Tweets
Big Black
• 18983 Tweets
Belem
• 14949 Tweets
Asher
• 14819 Tweets
#MebTekinDeğil
• 10042 Tweets
No benefit of immediate
#ECMO
in ECMO-CS trial
#AHA2022
. Will this change clinical practice? 40% cross-over rate, no venting strategy
@hvanspall
@AGIKinterv
12
109
319
The first 3 TriClip cases (after CE Mark) worldwide just performed at Heart Center Leipzig. Congrats to the team and the perfect results
18
50
294
PFO Occlusion in 3D. Nice images from a case this morning
@TobiasKister
@mvonroeder
@Mo_A_W
@sulimov_dmitry
7
70
284
We just made it!
#ECLS
-SHOCK last patient in just happened!!! Congrats to the whole team! Another milestone in
#cardiogenicshock
treatment!
@AGIKinterv
@KardiologieHH
@TRassafMD
@YoungDgk
@DGK_org
@AnneFreund3
@hvanspall
33
52
275
3
68
217
Tomahawk presented and published
@NEJM
@GFurnau
@dzhk_germany
@YoungDgk
@YoungDZHK
@DGK_org
@IngoEitel
@AGIKinterv
3
78
206
Last day
@PhilippLurz
after 21 years at Heart Center Leipzig. Now heading to become chief of cardiology at
@uni_mainz
. All the best for the start and great success!
@KP_Kresoja
11
6
189
This is where IABP console may have its place if you follow evidence 😉
@ajaykirtane
@AGIKinterv
@GFurnau
@mrubini
@YoungDgk
37
24
170
EMERGE trial just published
@JAMACardiology
@AnneFreund3
The next trial after
#Tomahawk
#Coact
not showing any benefit for immediate invasive strategy after
#OHCA
0
57
160
Slow flow/thrombus despite ECMELLA strategy with Impella 5.5 plus VA-ECMO.
@BenediktSchrage
@dirkwestermann
@AGIKinterv
@Steph_Achenbach
@ACVCPresident
@feistritzerH_J
@JaninePoss
@mrubini
9
42
161
The first Pascal tricuspid repair worldwide at Heart Center Leipzig after CE mark of the System for tricuspid position
6
22
162
The countdown starts. Only 5 patients to go for
#ECLS
-SHOCK trial. The first large scale trial of MCS in
#shock
.
@TRassafMD
@AnneFreund3
@AGIKinterv
@SrihariNaiduMD
@Drroxmehran
@hvanspall
@dzhk_germany
@YoungDgk
5
36
157
Successful VSD closure post AMI using VA-ECMO support. Patient already discharged.
@sulimov_dmitry
@Steph_Achenbach
@AGIKinterv
@YoungDgk
@mrubini
15
34
155
CHIP in cardiogenic shock. New marker of adverse prognosis
@JACCJournals
@AnneFreund3
@dzhk_germany
@StefanieDimmel1
@SCAI
@AGIKinterv
@UKL_Leipzig
2
51
148
Cardiac arrest and cardiogenic shock. How to treat? Just published
@mmamas1973
@GFurnau
@JaninePoss
@agtruesdell
@SVRaoMD
1
41
144
Congrats to Danger team
@CHassager
! Impressive results, now after SHOCK and Culprit-Shock 3rd positive RCT. Nevertheless, multiple questions remain: 1) is it the device? 2) patient selection? 3) treatment bias? 4) longer follow-up?
@seanvandiepen
@JBauersachsMD
@NavinKapur4
DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications.
@ShashankSinhaMD
@ShelleyZieroth
@JasonKatzMD
@thiele_holger
@DrDamluji
@agtruesdell
@Cardio_Girl
3
35
115
7
33
129
First MitraClip generation 4 in Europe just finished at Heart Center Leipzig! Perfect result with XT-W. Thank you to the team!
@AGIKinterv
@PhilippLurz
5
17
116
Some people said this is the most important slide of ACVC 😉
@carlosalviar
@JaninePoss
@GFurnau
@mrubini
@escardio
@ACVCPresident
8
15
119
Just published our debate on prasugrel vs ticagrelor and no routine pretreatment
@JBauersachsMD
@DirkSibbing
@ColletJeanphil1
@DLBHATTMD
@ESC_Journals
@ehj_ed
2
39
114
ECLS-SHOCK 400 patient award just presented to
@TobiasKister
at Heart Center Leipzig. 420 patient award goes to Ludwigshafen
@AGIKinterv
@Mo_A_W
@sulimov_dmitry
@AnneFreund3
@mrubini
@TRassafMD
@PCSchulzeMD
2
7
113
What to expect from upcoming MCS trials?
@AnneFreund3
@AGIKinterv
@ESC_Journals
@AGIKinterv
@VranckxPascal
@krychtiukmd
@hvanspall
4
49
111
Consistent data from propensity matched studies. More complications with Impella, no mortality benefit.
See Dhruva et al. JAMA 2020 and Amin et al. Circulation 2020 and Schrage et al. Circulation 2019. We urgently need RCTs!
#DanGer
#ECLS
-SHOCK
Impella vs. IABP in
@JAMAInternalMed
- Propensity-matched analysis
- 817 patients with AMI-CS undergoing PCI
- Impella associated with higher 30d/1yr mortality, more bleeding and RRT and higher costs
#Impella
#IABP
23
103
322
2
35
107
ECLS-SHOCK presenter and discussant
@alaide_chief
25 min before the start. Stay tuned
#ESCCongress
@Steph_Achenbach
@Drroxmehran
2
7
104
A picture for the historical museum. 😉 IABP in place in 2023
#Leipzig
@sulimov_dmitry
@KP_Kresoja
@AGIKinterv
@Drroxmehran
@IngoEitel
@GFurnau
@mmamas1973
@hvanspall
6
7
101
Lancet and NEJM
💥 breaking news 💥
Aktuell auf dem
#ESCCongress
von
@thiele_holger
vorgestellt und im
@lancet
veröffentlicht:
Die ECLS-SHOCK-Studie:
▶️ KEIN Vorteil für VA-ECMO im infarktbedingten kardiogenen Schock 💥
Nun gilt es zu analysieren, wer von der Therapie ggf. doch profitiert.
4
13
55
8
11
97
Wait for ECLS-SHOCK. No cross-over, clear venting strategy, mortality endpoint, N=420!
No benefit of immediate
#ECMO
in ECMO-CS trial
#AHA2022
. Will this change clinical practice? 40% cross-over rate, no venting strategy
@hvanspall
@AGIKinterv
12
109
319
2
24
97
Here the key messages on mechanical support in cardiogenic shock. RCTs: more complications, no signal on mortality reduction. Matched comparisons: more complications, higher mortality. We need RCTs!
@seanvandiepen
@Borjaibanez1
@alaide_chief
1
38
93
ECLS-SHOCK results will be presented in two days
#ESCCongress
.
Should I wear this T-Shirt during Hotline presentation?
@hvanspall
@cbgranger
@JaninePoss
@alaide_chief
@AnneFreund3
@YoungDgk
@DGK_org
14
11
93
here is the link to the TOMAHAWK paper
@NEJM
@AGIKinterv
@GFurnau
@IngoEitel
@dzhk_germany
@YoungDZHK
@Steph_Achenbach
@YoungDgk
@CHassager
1
14
92
Venting can also be done by pigtail catheter in LV connected to venous cannula of ECMO! Very cheap and effective way of venting!!!
@AGIKinterv
@sulimov_dmitry
@Babar_Basir
@JasonKatzMD
@seanvandiepen
@HenrytTimothy
@dirkwestermann
@BenediktSchrage
@NavinKapur4
@thiele_holger
Absolutely concur!
Importantly both IABP and Impella CP can do the venting job 🤷♂️
#small
profile
1
1
11
7
25
92
Comprehensive review on VA-ECMO
@DGK_AG3
@TRassafMD
We are happy to share our latest contribution to Circulation: Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence? | Circulation
@CircAHA
@thiele_holger
@LBinzenhofer
@cardio_lmu
1
8
28
1
26
90
See our recent cardiogenic shock treatment analysis
@CircAHA
@seanvandiepen
@AGIKinterv
@GFurnau
@susannaprice
1
23
88
ECLS-SHOCK trial presentation is about to start in 1 hour.
#ESCCongress
with chairmen
@Drroxmehran
@Steph_Achenbach
3
10
83
Interesting discussions. Some criticize that patients were too sick and others that patients were with SCAI C not sick enough for VA-ECMO. Is 50% mortality not clear that this were advanced shock patients? SCAI is nice but it is a dynamic and also partly subjective grading
Great study by
@thiele_holger
. Using VA ECMO as a go-to for shock doesn’t improve outcomes. Half of patients were SCAI stage C.Most high-quality centers don’t use ECMO for stage C shock. If you use ECMO early & often, you’re using it wrong. But the best way is still not known.
1
2
23
8
9
84
When to perform invasive coronary angiography after
#OHCA
? See our editorial to network metaanalysis.
@ESC_Journals
@AnneFreund3
@DGK_AG3
@ACVCPresident
0
30
83
I like the trial and the results. However, a treatment bias with more intensive care treatment as shown by the non-pathophysiological explainable RRT increase may also be a confounder of the trial results.
DanGer Shock! The first temporary mechanical support device shown to reduce mortality in patients with cardiogenic shock but there is an increased risk of complications.
@ShashankSinhaMD
@ShelleyZieroth
@JasonKatzMD
@thiele_holger
@DrDamluji
@agtruesdell
@Cardio_Girl
3
35
115
5
13
83
REVIVED neutral. PCI not beneficial over OMT in ischemic heart failure
#ESCCongress
@AGIKinterv
@YoungDgk
@JBauersachsMD
@mirvatalasnag
3
21
81
High intensity training against heart failure
@DGK_org
@YoungDgk
@JFdgthg
@Steph_Achenbach
#cardiotwitter
@herzprofessorin
2
3
81
Design and rationale of the ECLS-SHOCK trial published. Next milestone 200 patients. Honestly, I am extremely curious to see the results
@AGIKinterv
@SVRaoMD
@mmamas1973
@Steph_Achenbach
@dirkwestermann
0
30
79
Welcome to the ECLS-SHOCK party!
Now only 120 patients to go.
Hopefully by end of year 2022 finalized. ECLS-SHOCK will define if ECMO improves survival in
@SCAI
shock D + E stages
@NavinKapur4
@AGIKinterv
@dzhk_germany
We
@UKKoeln
are a little late to the
#ECLSSHOCK
party but motivated until the end! 300th patient Award for
#HeartTeamCologne
Thanks to
@thiele_holger
and team for this sweet and tasty surprise!
@AGIKinterv
@DGK_org
@VictorMauriMD
@MattiAdam_MD
@ElmarWKuhn
#ChristophAdler
3
6
38
3
16
80
Our novel objective CLIP cardiogenic shock score just published
@ESC_Journals
@AGIKinterv
@JaninePoss
@feistritzerH_J
@davebaran
0
27
79
Danke für Vertrauen. Fühle mich geehrt! 🙏
Herzlichen Glückwunsch aus Hamburg an den President- Elect der DGK
@thiele_holger
!!
#dgkjahrestagung
0
6
25
17
7
78
Giant LA with massive spontaneous contrast after TMVI. Looks like ghosts in LA
@Mo_A_W
@KP_Kresoja
@sulimov_dmitry
@Steph_Achenbach
@AGIKinterv
@YoungDgk
2
13
79
Coffee in the morning. Wait for ECLS-SHOCK trial results.
@TRassafMD
@AGIKinterv
@JaninePoss
@AlexMebazaa
@hvanspall
@AnneFreund3
@GFurnau
@DGK_AG3
9
10
78
summary slide of evidence for mechanical circulatory support. RCTs limited to 201 patients so far with no mortality reduction.5 matched comparisons all showing more complications and 4 higher mortality!!!
@susannaprice
@alaide_chief
@mmamas1973
@seanvandiepen
1
8
34
3
21
75
Heart team at play against atrial fibrillation.
@DGK_org
incoming president with
#Falk
@JFdgthg
president with
@Felix_Magath_
@AGEP_DGK
@Phiso_de
@YoungDgk
@AGIKinterv
@HerthaBSC
3
6
75
Honestly, I do not understand why people still believe in IABP. Is it because we want to help our patients with 50% mortality rate but do not have anything which has proven to work?
@drtrc99
Several randomized trials available and 66% of questionned people say yes...IABP doesn't have any role for CS (and probably for AMI related complications).
@thiele_holger
1
0
10
19
19
73
CHOICE-CLOSURE just presented and simultaneously published
@Mo_A_W
@TCTConference
@CircAHA
@AGIKinterv
@drnvanmieghem
2
15
74
Barcelona also famous for other things than
#ESCCongress
@GFurnau
@IngoEitel
@KP_Kresoja
7
3
74
Important update on SCAI shock classification!
SCAI SHOCK Stage Classification Expert Consensus Update released today in the inaugural issue of
@MyJSCAI
and also in
@JACCJournals
. Thank you to endorsing societies
@ACCinTouch
@american_heart
@ACEPNow
@escardio
@ACVCPresident
@ISHLT
@SCCM
@STS_CTsurgery
2
91
209
0
18
73
Strange conclusion based on a neutral trial
Slightly controversial conclusion that should get Twitter going:
7
11
30
6
9
72
This is the current status of ongoing MCS trials in cardiogenic shock. Help us to build the evidence we need by patient inclusion
@AGIKinterv
@IngoEitel
@TRassafMD
@dirkwestermann
@BenediktSchrage
@dzhk_germany
@DGK_org
0
23
72
First Trillium device for treatment of severe tricuspid regurgitation just implanted at Heart Center Leipzig
@PhilippLurz
@AGIKinterv
5
13
68
SOLVE-TAVI 1-year results just published
@JACCJournals
@feistritzerH_J
@Mo_A_W
@AGIKinterv
@HolgerNef
2
19
69
9
16
70
Start with a coffee in the morning. Which mug is the hottest? Wait for
#ESCCongress
hotline Saturday.
@AnneFreund3
@JaninePoss
@TRassafMD
@DGK_org
@YoungDgk
@DGK_AG3
@hvanspall
7
6
69
Heart Center Leipzig has just been awarded as expert educational center for young cardiologists
@YoungDgk
@mrubini
@JaninePoss
@KP_Kresoja
@RoschSeb
@sulimov_dmitry
@Mo_A_W
@AnneFreund3
@DGK_org
6
12
69
Not sure if I am Mr. Negative trial. CULPRIT-SHOCK was clearly positive. And neutral or negative trials reflect also scientific valid and usually well-conducted trials.
@GiuseppeGalati_
@azangrillo
@DrMarthaGulati
@KTamirisaMD
@mmamas1973
@JJheart_doc
@DrNasrien
@DrRajivsankar
@AnastasiaSMihai
@ValleAlfonso
@ShelleyZieroth
@JavedButler1
@FH_Verbrugge
I feel like
@thiele_holger
really specializes in removing the need for unnecessary procedures and interventions. I'll remember him as Mr. Negative Trial. And it's awesome.
7
0
6
3
5
68
#DGKHerztage
. This is the evidence regarding mortality reduction with
#PCI
and CABG. Only 1 very old RCT for CABG showing benefit. STICH also not state of the art
@AGIKinterv
@sulimov_dmitry
@KardiologieHH
3
17
67
420 (last patient in) patient award
#ECLS
-SHOCK
#Klinikum
Ludwigshafen. Waiting for the results now!
@AGIKinterv
@AnneFreund3
@dzhk_germany
@YoungDgk
@mrubini
@MarcVorpahl
@KardiologieHH
@dscharpfMD
4
9
68
1
5
66
Proud to be awarded once again as highly cited researcher in 2021 by
@clarivate
@HighlyCited2021
@dzhk_germany
@UKL_Leipzig
@DGK_org
@AGIKinterv
@UniLeipzig
@StadtLeipzig
7
1
63
Watch out for
#Hotline
#ESCCongress2023
@ESCardioNews
for our ECLS-SHOCK trial results
@JaninePoss
@AnneFreund3
@IngoEitel
@TRassafMD
@AGIKinterv
@PCSchulzeMD
@DGK_AG3
@DGK_org
@YoungDgk
0
18
64
Let us prepare for the second and third wave and reduce the collateral damage
2
33
62
ESC NST-ACS 2020 guidelines just published in print in current Eur Heart J issue
@ehj_ed
@ColletJeanphil1
@DLBHATTMD
@DirkSibbing
@AGIKinterv
0
21
63
Modern cardiologists take the train.
More CO2 efficient
5
4
63
4th year in a row among the most cited researchers. Thank you to the research team
@UniLeipzig
Heart Center Leipzig
@kp_rommel
@KP_Kresoja
@Mo_A_W
@PhilippLurz
@JaninePoss
@mvonroeder
@DGK_org
@dzhk_germany
4
3
62
Very very sad news. I had the chance to work with him over years in particular for
@escardio
NSTE-ACS guidelines 2020. I am shocked to have lost a friend
Very sad news today as my friend and great expert Pr Jean Philippe Collet let us suddenly. Great cardiologist and researcher, very kind with patients and team. I ´d rather keep him smiling. No words.
38
28
191
2
6
61
Thank you, we will do more of these guideline changing trials
A shout out to
@thiele_holger
& colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & their work will meaningfully impact lives of patients.
1st study:
1-year outcomes:
1
6
24
3
10
60
Thank you for voting for ECLS-SHOCK as most impactful trial
#ESCCongress
@YoungDgk
@DGK_org
@AnneFreund3
@JaninePoss
@TRassafMD
What are the most impactful trials presented at
#ESCCongress
and why?
ECLS Shock showing ECMO does not improve survival in CS shock?
ILUMIEN 4 showing no improvement in outcomes 2 yrs later with OCT over angio?
Stop DAPT 3 showing we still need 1 month of DAPT?
12
18
48
1
4
59
Recipients - Highly Cited | Researcher Recognition
I am proud and privileged to be for first time among the 6200 highly cited researchers in 2020
@Steph_Achenbach
@DLBHATTMD
In Germany 16 cardiologists awarded
9
4
57
Catch it! Pulmonary embolism by
@sulimov_dmitry
@AnneFreund3
@KP_Kresoja
@AGIKinterv
@YoungDgk
@echo_stepbystep
1
18
56
German
@YoungDgk
and some older guys meet
@DGK_org
booth
#ESCCongress
@KardiologieHH
@Hannah_Billig_
@Kardiophil
@TRassafMD
@JBauersachsMD
2
10
56
Great
#3CTmeeting2023
at French embassy in Washington. Import think tank on trials in
#shock
and heart failure
@hvanspall
@AlexMebazaa
@JaninePoss
0
3
54
Acute heart failure, acute cardiac care and cardiogenic shock researchers meet at
#GREAT
meeting in Berlin
@AlexMebazaa
@hvanspall
@J_Boeddinghaus
2
9
55
See the new ESC NSTE-ACS 2020 guidelines. Tomorrow 15:30 h live online
@ESCCongress
@ColletJeanphil1
@DLBHATTMD
@DirkSibbing
@AlexanderJobs3
@RoffiMarco
@JBauersachsMD
@EmanueleBarba13
@EkateriniL
2
18
52
Just published our review on artificial intelligence in cardiovascular disease
@BasicResCardiol
@KP_Kresoja
@PhilippLurz
@m_unterhuber
@YoungDZHK
@dzhk_germany
@YoungDgk
2
8
51
Discussion on new valve guidelines. The 75 year cut-off for TAVR vs SAVR justified?
@Drroxmehran
@MartyMleon
@ColletJeanphil1
@AGIKinterv
@Steph_Achenbach
0
13
53
Important work!
If you use ECMO consider early venting!
Great to see our
#ECMELLA
paper out finally. Took some time and lots of work of all the authors. Thanks to
@BenediktSchrage
for putting this together. Very well deserved!
@thiele_holger
@Babar_Basir
@mmamas1973
@ELSOOrg
@AGIKinterv
@DGK_org
5
42
117
1
7
53
Is interventional LAE therapy the next focus in interventional cardiology? FlowTriever result from LAE patient
@AGIKinterv
@sulimov_dmitry
@JaninePoss
@KP_Kresoja
@mrubini
#LAE
3
13
53
ADVOR trial shows highly relevant benefit for acetazolamide. NNT=6. Largest diuretic trial in
#CHF
#ESCCongress
@mirvatalasnag
@DGK_org
@YoungDgk
@JBauersachsMD
1
10
53
1
3
52
How does it look when the footprint 👣 of the mentor is too big? See the typical image 😉
@IngoEitel
@GFurnau
@RolandTilz
@TobiasKister
2
2
51
BOX trial restrictive vs higher oxygen no effect on mortality in
#OHCA
#ESCCongress
@mirvatalasnag
@JBauersachsMD
@AGIKinterv
@feistritzerH_J
@YoungDgk
0
20
52
Our review on cardiogenic shock within the top downloaded articles in 2019 at Eur Heart Journal!
4
4
51
Only 2 patients to go until 420 randomized patients in
#ECLS
-SHOCK
@PCSchulzeMD
@TRassafMD
@AnneFreund3
@AGIKinterv
@DGK_AG3
@hvanspall
0
6
51
Mannheim
@DGK_org
Jahrestagung 2022. Good bye and see you next year
@AGIKinterv
@AGEP_DGK
@YoungDgk
@Echo_DGK_GER
@AG21_DGK
0
6
50
Reminder and motivation for last few patients to be included in
#ECLS
-SHOCK
@AGIKinterv
@TRassafMD
@dscharpfMD
@IngoEitel
@AnneFreund3
@sulimov_dmitry
@DGK_AG3
2
4
51
4000 follower over night. Long way to 10.000 😉 Thank you 🙏
#cardiotwitter
@KardiologieHH
@AGIKinterv
@echo_stepbystep
4
2
49
New case. If it becomes more complex than initially thought
@KP_Kresoja
@AGIKinterv
@mrubini
@sulimov_dmitry
@YoungDgk
@DGK_AG3
@echo_stepbystep
2
17
48
Kurzbericht des Präsidenten
@DGK_org
@YoungDgk
@AGIKinterv
@DGK_AG3
@Echo_DGK_GER
@AGEP_DGK
@PG13_DGK
@AG21_DGK
1
18
48
Main short summary on NST-ACS Guidelines
@DLBHATTMD
@EmanueleBarba13
@DFCapodanno
@EkateriniL
@DirkSibbing
@RoffiMarco
@MichelZedBay
@JBauersachsMD
@AlexanderJobs3
@ColletJeanphil1
@Herzstiftung
@esccongress
1
18
48
Important for our ECLS-SHOCK trial. If you use ECMO have a strategy for unloading. We defined criteria for initiation of venting in the protocol
An international, multicenter cohort study finds LV unloading was associated with lower mortality in cardiogenic shock patients treated with VA-ECMO, despite higher complication rates
#AHAJournals
@SunnyVMD
@thiele_holger
4
41
109
0
10
47
Fully agree. I still do not understand the 60% mortality in control. This is the highest ever reported mortality rate in contemporary PCI era. We did this analysis for all our RCTs and mortality is <50% for the DanGer eligible cohort!
@GreggWStone
Great to have hope - but it’s a fragile result and we’ve seen too many times small trial findings reversed. Recover is needed to confirm/refute
1
0
9
8
6
48
Tomahawk trial 12 months just presented
#ESCCongress
. Mortality borderline different (although not significant)
@AGIKinterv
@DGK_AG3
@mmamas1973
@AnneFreund3
@JaninePoss
1
15
46
Important manuscript considering multiple options for unloading and venting to prevent pulmonary edema
@AGIKinterv
@sulimov_dmitry
@vlgmrc
@dirkwestermann
@GFurnau
@Anna_L_Meyer
@AnneFreund3
@JasonKatzMD
@seanvandiepen
Prevention and treatment of pulmonary congestion in patients undergoing VA-ECMO for cardiogenic shock
#CardioEd
#Cardiotwitter
@ESC_Journals
#ECMO
#ECLS
0
37
115
1
14
47
Thank you, Sunil. Science is the way to improve outcome.
This is a very unfortunate comment and really unfair to the all of the people and work that went into ECLS Shock.
Dogma is what limits progress.
We need to do the science or appreciate those who do.
2
4
40
4
1
46